Expression of Hes-1 (Notch-1 Effector) during “In Vitro” Normal Erythroid Differentiation.
Maria Domenica Cappellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Paola Comi(University of Milan), Elisabetta Calzavara(Ospedale Valduce), Raffaella Chiaramonte(University of Milan), Luisa Ronzoni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), I.V. Libani(University of Milan)
Cited by 0
Related Papers
Thalassaemia
|The Lancet|2017|763
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
|Haematologica|2014|389
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia
|British Journal of Haematology|2000|292
Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia
|British Journal of Haematology|2000|214